These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34595378)

  • 1. Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies.
    Chikaev AN; Chikaev AN; Rudometov AP; Merkulyeva YA; Karpenko LI
    Vavilovskii Zhurnal Genet Selektsii; 2021 Sep; 25(5):562-572. PubMed ID: 34595378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.
    Chikaev AN; Bakulina AY; Burdick RC; Karpenko LI; Pathak VK; Ilyichev AA
    PLoS One; 2015; 10(3):e0120847. PubMed ID: 25785734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of monoclonal antibody fragments from phage display libraries.
    Arbabi-Ghahroudi M; Tanha J; MacKenzie R
    Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.
    Huang W; Soeung V; Boragine DM; Hu L; Prasad BVV; Estes MK; Atmar RL; Palzkill T
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
    Choudhry V; Zhang MY; Sidorov IA; Louis JM; Harris I; Dimitrov AS; Bouma P; Cham F; Choudhary A; Rybak SM; Fouts T; Montefiori DC; Broder CC; Quinnan GV; Dimitrov DS
    Virology; 2007 Jun; 363(1):79-90. PubMed ID: 17306322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.
    Keller PM; Arnold BA; Shaw AR; Tolman RL; Van Middlesworth F; Bondy S; Rusiecki VK; Koenig S; Zolla-Pazner S; Conard P
    Virology; 1993 Apr; 193(2):709-16. PubMed ID: 7681612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.
    Bakhshinejad B; Zade HM; Shekarabi HS; Neman S
    Amino Acids; 2016 Dec; 48(12):2699-2716. PubMed ID: 27650972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and Antibody Engineering by Phage Display.
    Frei JC; Lai JR
    Methods Enzymol; 2016; 580():45-87. PubMed ID: 27586328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased selection of propagation-related TUPs from phage display peptide libraries.
    Zade HM; Keshavarz R; Shekarabi HSZ; Bakhshinejad B
    Amino Acids; 2017 Aug; 49(8):1293-1308. PubMed ID: 28664268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Characterization of Cross-Neutralizing Human Anti-V3 Single-Chain Variable Fragments (scFvs) Against HIV-1 from an Antigen Preselected Phage Library.
    Kumar R; Kumari R; Khan L; Sankhyan A; Parray HA; Tiwari A; Wig N; Sinha S; Luthra K
    Appl Biochem Biotechnol; 2019 Mar; 187(3):1011-1027. PubMed ID: 30151637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.
    Hassapis KA; Stylianou DC; Kostrikis LG
    Viruses; 2014 Dec; 6(12):5047-76. PubMed ID: 25525909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection.
    Tikunova NV; Morozova VV
    Acta Naturae; 2009 Oct; 1(3):20-8. PubMed ID: 22649612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries.
    Dieltjens T; Willems B; Coppens S; Van Nieuwenhove L; Humbert M; Dietrich U; Heyndrickx L; Vanham G; Janssens W
    J Virol Methods; 2010 Oct; 169(1):95-102. PubMed ID: 20637241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.
    Sun Z; Yan L; Tang J; Qian Q; Lenberg J; Zhu D; Liu W; Wu K; Wang Y; Lu S
    Virus Res; 2018 Jan; 243():75-82. PubMed ID: 29051051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.